These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Delaware
|
|
26-0884348
|
|
(State or other jurisdiction of incorporation
or organization)
|
|
(IRS Employer
Identification No.)
|
|
101 Hudson Street, 21
st
Floor, Jersey City, New Jersey 07302
|
|
(Address of principal executive offices)
|
|
o
|
Large accelerated filer Accelerated filer
|
o
|
Accelerated filer
|
|
o
|
Non-accelerated filer (Do not check if a smaller reporting company)
|
x
|
Smaller reporting company
|
|
|
|
Page
|
|
|
|
|
|
|
||
|
|
|
|
|
ITEM 1.
|
FINANCIAL STATEMENTS (Unaudited)
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2013 and December 31, 2012
|
F-1
|
|
|
|
|
|
|
Condensed Consolidated Statements of Operations for the three months ended March 31, 2013 and March 31, 2012
|
F-2
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2013 and March 31, 2012
|
F-3
|
|
|
|
|
|
|
Notes to the Condensed Consolidated Financial Statements
|
F-4
|
|
|
|
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
3
|
|
|
|
|
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
4
|
|
|
|
|
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
6
|
|
|
|
|
|
ITEM 1A.
|
RISK FACTORS
|
6
|
|
|
|
|
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
6
|
|
|
|
|
|
ITEM 3.
|
DEFAULTS UPON SENIOR SECURITIES
|
6
|
|
|
|
|
|
ITEM 4.
|
MINE SAFETY DISCLOSURE
|
6
|
|
|
|
|
|
ITEM 5.
|
OTHER INFORMATION
|
6
|
|
|
|
|
|
ITEM 6.
|
EXHIBITS
|
6
|
|
|
|
|
|
SIGNATURES
|
8
|
|
|
|
March 31,
2013
|
December 31,
2012
|
||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
|
|
||||||
|
Cash
|
$ | 138,900 | $ | 1,379 | ||||
|
Inventory
|
33,999 | 22,820 | ||||||
|
Supplier Deposits
|
134,470 | - | ||||||
|
Prepaid Expenses
|
4,280 | 5,807 | ||||||
|
Total Current Assets
|
311,649 | 30,006 | ||||||
|
|
||||||||
|
PROPERTY AND EQUIPMENT, net of accumulated depreciation
|
3,497 | 2,243 | ||||||
|
|
||||||||
|
OTHER ASSETS
|
||||||||
|
Security deposits
|
5,798 | 5,798 | ||||||
|
|
||||||||
|
TOTAL ASSETS
|
$ | 320,944 | $ | 38,047 | ||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 124,298 | $ | 349,729 | ||||
|
Notes payable to related parties
|
- | 187,500 | ||||||
|
Derivative liabilities - Preferred Stock
|
159,949 | - | ||||||
|
Total Current Liabilities
|
284,247 | 537,229 | ||||||
|
Commitments and Contingencies
|
- | - | ||||||
|
|
||||||||
|
Series A Preferred Stock, $0.001 par value, 197,708.5 and 0 shares issued and outstanding, respectively
|
790,834 | - | ||||||
|
STOCKHOLDERS' DEFICIT
|
||||||||
|
Preferred stock, 10,000,000 authorized at $0.001 par value
|
- | - | ||||||
|
Common stock, 190,000,000 shares authorized at $0.001 par value, 8,551,265 shares issued and outstanding
|
8,551 | 8,551 | ||||||
|
Additional paid in capital
|
10,106,715 | 9,838,024 | ||||||
|
Accumulated deficit
|
(10,869,403 | ) | (10,345,757 | ) | ||||
|
Total Stockholders' Deficit
|
(754,137 | ) | (499,182 | ) | ||||
|
|
||||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$ | 320,944 | $ | 38,047 | ||||
|
|
Three Months Ended
March 31,
|
|||||||
|
|
2013
|
2012
|
||||||
|
Revenues
|
$ | - | $ | - | ||||
|
|
||||||||
|
Cost of Revenues
|
- | - | ||||||
|
|
||||||||
|
Gross Profit
|
- | - | ||||||
|
|
||||||||
|
Operating Expenses
|
||||||||
|
General and administrative
|
520,502 | 224,005 | ||||||
|
Total Operating Expenses
|
520,502 | 224,005 | ||||||
|
|
||||||||
|
Loss from operations
|
(520,502 | ) | (224,005 | ) | ||||
|
Other Expenses
|
||||||||
|
Interest expense
|
1,658 | - | ||||||
|
Loss on change in fair value of derivative liabilities
|
1,486 | - | ||||||
|
Total Other Expenses
|
3,144 | - | ||||||
|
Loss Before Provision for Income Taxes
|
(523,646 | ) | (224,005 | ) | ||||
|
|
||||||||
|
Provision for Income Taxes
|
- | - | ||||||
|
|
||||||||
|
Net Loss
|
$ | (523,646 | ) | $ | (224,005 | ) | ||
|
Preferred stock dividend
|
$ | 158,463 | $ | - | ||||
|
Net Loss available to common stockholders
|
$ | (682,109 | ) | $ | (224,005 | ) | ||
|
Net Loss available to common stockholders, basis and fully diluted
|
$ | (0.08 | ) | $ | (0.06 | ) | ||
|
|
||||||||
|
Basic and diluted weighted average number of common shares outstanding
|
8,551,265 | 3,909,278 | ||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$ | (523,646 | ) | $ | (224,005 | ) | ||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation
|
213 | - | ||||||
|
Deferred stock compensation
|
427,154 | 130,000 | ||||||
|
Loss on change in fair value of derivative liabilities
|
1,486 | - | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in inventory
|
(11,179 | ) | - | |||||
|
Increase in supplier deposits
|
(134,470 | ) | - | |||||
|
Decrease in prepaid expenses
|
1,527 | - | ||||||
|
Increase (decrease) in accounts payable and accrued expenses
|
(84,231 | ) | 79,005 | |||||
|
Net cash used in operating activities
|
(323,146 | ) | (15,000 | ) | ||||
|
Net cash used in investing activities:
|
||||||||
|
Purchases of property and equipment
|
(1,467 | ) | - | |||||
|
Net cash used in investing activities
|
(1,467 | ) | - | |||||
|
Net cash provided by financing activities:
|
||||||||
|
Notes payable to related parties
|
50,000 | 15,000 | ||||||
|
Issuance of preferred stock
|
412,134 | - | ||||||
|
Net cash provided by financing activities
|
462,134 | 15,000 | ||||||
|
Net increase in cash and cash equivalents
|
137,521 | - | ||||||
|
Cash and cash equivalents at beginning of period
|
1,379 | - | ||||||
|
Cash and cash equivalents at end of period
|
$ | 138,900 | $ | - | ||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
|
Interest paid
|
$ | 7,262 | $ | - | ||||
|
Taxes paid
|
$ | - | $ | - | ||||
|
NON CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
|
Preferred stock issued for the conversion of debt
|
$ | 378,700 | $ | - | ||||
|
Accrued compensation converted to notes payable to related parties
|
$ | 141,200 | $ | - | ||||
|
·
|
Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
|
|
|
·
|
Level 2 Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;
|
|
|
·
|
Level 3 Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).
|
|
Balance Sheet
Location
|
Quoted Prices in
Active Markets for Identical Assets or
Liabilities
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable
Inputs
(Level 3)
|
Total | |||||||||
|
Liabilities:
|
|||||||||||||
|
Derivative liabilities
|
$ |
-
|
$ |
-
|
$ |
159,949
|
$ |
159,949
|
|||||
|
Balance at beginning of period
|
$ | - | ||
|
Recognition of embedded derivative liabilities
|
158,463 | |||
|
Change in fair value of derivative liabilities
|
1,486 | |||
|
Balance at end of period
|
$ | 159,949 |
|
Exhibit No.
|
Description
|
|
|
3.1
|
Certificate of Amendment to Certificate of Incorporation of Mojo Organics, Inc. (1)
|
|
|
3.2
|
Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (2)
|
|
|
10.1
|
Amended and Restated Securities Purchase Agreement (2)
|
|
|
10.2
|
Registration Rights Agreement (2)
|
|
|
10.3
|
Commitment letter executed by each of Glenn Simpson, Jeffrey Devlin and Richard Seet (2)
|
|
|
10.4
|
Amendment to Richard X. Seet Restricted Stock Agreement (2)
|
|
|
10.5
|
Letter Agreement relating to nominee right of OmniView Capital LLC (2)
|
|
|
10.6
|
Employment Agreement dated March 1, 2013 between Mojo Organics, Inc. and Glenn Simpson (3)
|
|
|
10.7
|
2012 Long-Term Incentive Equity Plan (3)
|
|
|
10.8
|
Form of Stock Option Agreement under the 2012 Long-Term Incentive Equity Plan (3)
|
|
|
31.1/31.2
|
*
|
Certification of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1/32.2
|
*
|
Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
**
|
XBRL Instance Document
|
|
101.SCH
|
**
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
**
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
**
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
**
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
**
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
(1)
|
Filed as an exhibit with the Registrant’s Current Report on Form 8-K filed on April 2, 2013 and incorporated herein by reference.
|
|
(2)
|
Filed as an exhibit with the Registrant’s Current Report on Form 8-K filed on February 1, 2013 and incorporated herein by reference.
|
|
(3)
|
Filed as an exhibit to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2012 and incorporated herein by reference.
|
| MOJO ORGANICS, INC. | ||
|
Dated: September 26, 2013
|
By:
|
/s/Glenn Simpson
|
|
Glenn Simpson, Chief
Executive Officer and Chairman
(Principal Executive and Principal Financial and Accounting Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|